Fusion’s R&D team has developed ways to connect alpha emitting medical isotopes to molecules which selectively target biomarkers found on the surface of cancer cells.
Targeted Alpha Therapeutics
The Science Behind
Alpha particles emitted from medical isotopes can be used to kill cancer cells by creating lethal, double stranded DNA breaks. Unlike most radiation therapies, alpha particles travel only one to three cell lengths, thereby creating the means to selectively kill tumor cells.
At Fusion Pharma, we’re harnessing this potent and precise cell killing strategy to treat cancers via “targeted alpha therapeutics.”